{"nct_id":"NCT01502423","title":"A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab","status":"COMPLETED","status_verified_date":"2014-01","start_date":"2012-01","start_date_type":null,"primary_completion_date":"2012-11","primary_completion_date_type":"ACTUAL","completion_date":"2012-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}